miRNA and target gene expression in menstrual endometria and early pregnancy decidua.
Hohhot, China. In Eur J Obstet Gynecol Reprod Biol, Dec 2015
In addition, the decidua had significantly lower levels of expression of LIF, IL6, MMP2, MMP10, and IGF2R and higher levels of expression of SGK1, LEPR, PROK1, and STAT3 than the menstrual endometria group.
The multiple roles of EG-VEGF/PROK1 in normal and pathological placental angiogenesis.
Grenoble, France. In Biomed Res Int, 2013
In the last decade, endocrine gland derived vascular endothelial growth factor (EG-VEGF), also called prokineticin 1 (PROK1), has emerged as specific placental angiogenic factor that controls many aspects of normal and pathological placental angiogenesis such as recurrent pregnancy loss (RPL), gestational trophoblastic diseases (GTD), fetal growth restriction (FGR), and preeclampsia (PE).
Prokineticins in angiogenesis and cancer.
Rennes, France. In Cancer Lett, 2010
The mammalian orthologs consist of two prokineticin peptides, prokineticin 1 (PROK1) and prokineticin 2 (PROK2) that signal through two G-protein coupled receptors: prokineticin receptor 1 (PROKR1) and prokineticin receptor 2 (PROKR2).
Bv8 regulates myeloid-cell-dependent tumour angiogenesis.
San Francisco, United States. In Nature, 2008
We have previously shown that the related EG-VEGF and Bv8 proteins, also known as prokineticin 1 (Prok1) and prokineticin 2 (Prok2), promote both tissue-specific angiogenesis and haematopoietic cell mobilization.